Literature DB >> 17077325

ATM deficiency disrupts Tcra locus integrity and the maturation of CD4+CD8+ thymocytes.

Irina R Matei1, Rebecca A Gladdy, Lauryl M J Nutter, Angelo Canty, Cynthia J Guidos, Jayne S Danska.   

Abstract

Mutations in ATM (ataxia-telangiectasia mutated) cause ataxia-telangiectasia (AT), a disease characterized by neurodegeneration, sterility, immunodeficiency, and T-cell leukemia. Defective ATM-mediated DNA damage responses underlie many aspects of the AT syndrome, but the basis for the immune deficiency has not been defined. ATM associates with DNA double-strand breaks (DSBs), and some evidence suggests that ATM may regulate V(D)J recombination. However, it remains unclear how ATM loss compromises lymphocyte development in vivo. Here, we show that T-cell receptor beta (TCRbeta)-dependent proliferation and production of TCRbeta(low) CD4+CD8+ (DP) thymocytes occurred normally in Atm-/- mice. In striking contrast, the postmitotic maturation of TCRbeta(low) DP precursors into TCRbeta(int) DP cells and TCRbeta(hi) mature thymocytes was profoundly impaired. Furthermore, Atm-/- thymocytes expressed abnormally low amounts of TCRalpha mRNA and protein. These defects were not attributable to the induction of a BCL-2-sensitive apoptotic pathway. Rather, they were associated with frequent biallelic loss of distal Va gene segments in DP thymocytes, revealing that ATM maintains Tcra locus integrity as it undergoes V(D)J recombination. Collectively, our data demonstrate that ATM loss increases the frequency of aberrant Tcra deletion events, which compromise DP thymocyte maturation and likely promote the generation of oncogenic TCR translocations.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17077325     DOI: 10.1182/blood-2006-05-020917

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  27 in total

1.  A novel mouse model for ataxia-telangiectasia with a N-terminal mutation displays a behavioral defect and a low incidence of lymphoma but no increased oxidative burden.

Authors:  Andrew Campbell; Brittany Krupp; Jared Bushman; Mark Noble; Christoph Pröschel; Margot Mayer-Pröschel
Journal:  Hum Mol Genet       Date:  2015-08-26       Impact factor: 6.150

Review 2.  DNA damage and repair during lymphoid development: antigen receptor diversity, genomic integrity and lymphomagenesis.

Authors:  Nahum Puebla-Osorio; Chengming Zhu
Journal:  Immunol Res       Date:  2008       Impact factor: 2.829

Review 3.  Unique and redundant functions of ATM and DNA-PKcs during V(D)J recombination.

Authors:  Eric J Gapud; Barry P Sleckman
Journal:  Cell Cycle       Date:  2011-06-15       Impact factor: 4.534

4.  Repair of chromosomal RAG-mediated DNA breaks by mutant RAG proteins lacking phosphatidylinositol 3-like kinase consensus phosphorylation sites.

Authors:  Eric J Gapud; Baeck-Seung Lee; Grace K Mahowald; Craig H Bassing; Barry P Sleckman
Journal:  J Immunol       Date:  2011-07-08       Impact factor: 5.422

Review 5.  At the intersection of DNA damage and immune responses.

Authors:  Jeffrey J Bednarski; Barry P Sleckman
Journal:  Nat Rev Immunol       Date:  2019-04       Impact factor: 53.106

6.  Disturbed B and T cell homeostasis and neogenesis in patients with ataxia telangiectasia.

Authors:  Matan Kraus; Atar Lev; Amos J Simon; Inbal Levran; Andrea Nissenkorn; Yonit B Levi; Yackov Berkun; Ori Efrati; Ninette Amariglio; Gideon Rechavi; Raz Somech
Journal:  J Clin Immunol       Date:  2014-05-01       Impact factor: 8.317

7.  ATM deficiency impairs thymocyte maturation because of defective resolution of T cell receptor alpha locus coding end breaks.

Authors:  Melanie S Vacchio; Alexandru Olaru; Ferenc Livak; Richard J Hodes
Journal:  Proc Natl Acad Sci U S A       Date:  2007-04-03       Impact factor: 11.205

8.  Aberrant V(D)J recombination in ataxia telangiectasia mutated-deficient lymphocytes is dependent on nonhomologous DNA end joining.

Authors:  Andrea L Bredemeyer; Ching-Yu Huang; Laura M Walker; Craig H Bassing; Barry P Sleckman
Journal:  J Immunol       Date:  2008-08-15       Impact factor: 5.422

9.  Genetic fingerprinting of the development and progression of T-cell lymphoma in a murine model of atypical myeloproliferative disorder initiated by the ZNF198-fibroblast growth factor receptor-1 chimeric tyrosine kinase.

Authors:  Mingqiang Ren; Xiurong Li; John K Cowell
Journal:  Blood       Date:  2009-06-08       Impact factor: 22.113

10.  Histone H2AX stabilizes broken DNA strands to suppress chromosome breaks and translocations during V(D)J recombination.

Authors:  Bu Yin; Velibor Savic; Marisa M Juntilla; Andrea L Bredemeyer; Katherine S Yang-Iott; Beth A Helmink; Gary A Koretzky; Barry P Sleckman; Craig H Bassing
Journal:  J Exp Med       Date:  2009-11-02       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.